Godavari Drugs Ltd — Updates, 29-05-2025: Company Update

Godavari Drugs Limited has announced a board meeting outcome where it approved the audited financial results for the quarter and financial year ended March 31, 2025, with the auditor’s report reflecting an unmodified opinion. Two Independent Directors, Mr. Syed Anis Hussain and Mrs. Vimala Behram Madon, will complete their second terms by June 23, 2025. Mrs. Shilpa Bung has been appointed as an Additional Independent Director for five years, pending shareholder approval. The Board reconstituted key committees and approved new appointments for Internal Auditors, Secretarial Auditors (five years), and Cost Auditors (one year). The 37th Annual General Meeting will be held via video conferencing. No defaults on loans or debt securities were reported. Related party transactions totaling ₹2.10 Cr were disclosed, primarily involving director remuneration, rent, loans, and interest income.